Veratraldoxime

CAS : 2169-98-4

Ref. 3D-FV67644

Informations sur le produit

• Nom: Veratraldoxime
• Synonymes: 3,4-Dimethoxybenzaldehyde oxime

Description

Veratraldoxime is a synthetic compound that is the diacetate ester of oxime and has been used in the treatment of inflammatory bowel disease. It has been shown to be effective in some patients, but not all, with ulcerative colitis. Veratraldoxime inhibits the production of inflammatory mediators by inhibiting the activity of cyclooxygenase-2 and lipoxygenase. This drug also has anti-inflammatory properties by inhibiting prostaglandin synthesis at the level of phospholipase A2 and cyclooxygenase-1. The mechanism of action for this drug is similar to that of other nonsteroidal anti-inflammatory drugs (NSAIDs). Veratraldoxime also inhibits protein synthesis by blocking the formation of amide bonds, thereby inhibiting bacterial growth. The oxidation products are responsible for its antibiotic properties. Veratraldoxime binds to copper chromite to form a coordination complex, which is

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 181.19 g/mol
• Formule: C₉H₁₁NO₃
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder
• InChI: InChI=1S/C9H11NO3/c1-12-8-4-3-7(6-10-11)5-9(8)13-2/h3-6,11H,1-2H3/b10-6+
• Code InChI: InChIKey=LHZIVRAMZJJLAP-UXBLZVDNSA-N
• SMILES: COc1ccc(/C=N/O)cc1OC